Ana Luísa Teixeira is currently a Junior Researcher in the Molecular Oncology and Viral Pathology Group at the Portuguese Oncology Institute of Porto Research Center (CI-IPOP). She obtained her BSc in Biology (2006/ FCUP), MSc in Oncology (2009/ ICBAS-UP) and PhD in Biomedical Sciences (2014/ ICBAS-UP) at the University of Porto. She began her career as Researcher in the Molecular Oncology and Viral Pathology Group (MOVP) at the CI-IPOP in 2006, having progressed the post-graduate training in the same Institution in collaboration with I3S/IPATIMUP and the Department of Genetics of the University of Groningen. Her research area focused on oncobiology, more specifically the study of predictive molecular biomarkers (genetic and epigenetic) associated with tumor development and metastasis formation, which culminated in the implementation and optimization of different laboratory techniques (molecular biology and cell culture) that contributed to the scientific and technical growth of the Group. She has authored or co-author 64 international scientific publications and 6 book chapters (h-index 19). Until now, she has supervised 13 master and 3 first degree students, respectively and co-supervised 3 PhD, 16 master and 3 first degree students, respectively. Since 2019, she is risk lab manager, being involved in laboratory risk management, which include the risk identification and the development of laboratory safety mesures and practices. Additionally, she is also involved in Group managment activities, including human resources management, implementation of laboratory techniques, equipment management and participation in reagent and equipment selection processes. Moreover, she is also an invited Professor at Institute of Biomedical Sciences Abel Salazar (ICBAS-UP). This synergic role allows the dissemination of her scientific knowledge, as well as the training of younger students. Her actual field of interest is focused on the study of extracellular vesicles cargo in order to identify new cancer molecular biomarkers with potential to be used as liquid biopsies and targets for new therapeutic approaches.